Business Context and Reporting Period
Hippo Holdings Inc. filed this Form 8-K on August 5, 2021, reporting events occurring primarily on August 2, 2021. The filing documents the completion of the domestication of Reinvent Technology Partners Z (“RTPZ”) from a Cayman Islands company to a Delaware corporation, its name change to Hippo Holdings Inc., and the merger with Hippo Enterprises Inc. Hippo Holdings ceased to be a shell company and became the successor issuer to RTPZ.
Hippo common stock and warrants began trading on the New York Stock Exchange on August 3, 2021 under the symbols HIPO and HIPO.WS, respectively.
Key Financial and Capitalization Metrics
- Hippo’s pre-transaction equity value was $5.522 billion, based on 552.2 million shares of merger consideration valued at $10.00 per share.
- The PIPE investment provided gross proceeds of approximately $550 million through the issuance of 55 million shares at $10.00 per share.
- Hippo Holdings used $95 million to acquire 9.5 million shares from certain pre-business-combination Hippo stockholders.
- RTPZ redeemed 19,261,380 Class A shares in connection with the transaction.
- Following the Business Combination, PIPE investment, redemptions and unit separation, 559,731,226 shares of common stock were issued and outstanding.
- The filing does not provide a clear post-transaction revenue, net income, cash flow, margin, debt, cash balance or liquidity value. Historical financial statements and pro forma information are incorporated by reference rather than reproduced in the filing text.
Material Changes Versus the Prior Comparable Period
- RTPZ was converted into a Delaware corporation and renamed Hippo Holdings Inc.
- Hippo Enterprises became a wholly owned subsidiary through the first merger and was then merged into Hippo Holdings, with Hippo Holdings surviving.
- Hippo preferred stock converted into common stock, Hippo notes converted into common stock, and outstanding Hippo options were converted into options to purchase Hippo Holdings common stock.
- RTPZ warrants converted into Hippo Holdings warrants; Hippo warrants were exercised or terminated in accordance with their terms.
- Ownership after the transaction was reported as approximately 89.5% for pre-business-combination Hippo stockholders, 9.0% for third-party PIPE investors, 0.6% for former RTPZ public shareholders and 0.9% for the RTPZ sponsor and certain former independent directors, subject to the assumptions described in the filing.
- New directors and executive officers were appointed, including Assaf Wand as Chief Executive Officer, Richard McCathron as President, Stewart Ellis as Chief Financial Officer, Ran Harpaz as Chief Technology Officer, Simon Fleming-Wood as Chief Marketing Officer and Aviad Pinkovezky as Chief Product Officer.
Guidance, Outlook, Risks and Unusual Items
No new quantitative financial guidance is provided in this Form 8-K. The filing incorporates prior projections, historical financial statements, management discussion and analysis, and risk factors from the proxy statement/prospectus.
- Management identifies risks relating to achieving growth and profitability, customer acquisition and retention, competition, insurance underwriting, reinsurance availability, regulatory compliance, capital requirements and seasonal fluctuations.
- Other cited risks include cybersecurity and data privacy, intellectual property protection, dependence on technology and internet search methodologies, personnel retention, COVID-19 effects, and the ability to maintain NYSE listing and public-market liquidity.
- The company states that it does not currently anticipate declaring dividends in the foreseeable future.
- A putative Telephone Consumer Protection Act class action filed in June 2021 was voluntarily dismissed without prejudice on July 23, 2021.
- The company adopted a non-employee director compensation program, including annual cash retainers and equity grants, and entered into registration rights and director and officer indemnification arrangements.
Most Important Facts for Investors to Verify
- Review the audited Hippo and Spinnaker financial statements and the unaudited pro forma combined financial information incorporated by reference and filed as Exhibit 99.1.
- Reconcile the reported 559.7 million shares outstanding with merger consideration, PIPE shares, redemptions, option rollovers and potential warrant or option dilution.
- Confirm the company’s post-closing cash balance, liquidity runway, debt obligations and use of PIPE and transaction proceeds.
- Evaluate actual operating results against the projections and growth assumptions in the proxy statement/prospectus.
- Assess the effect of insurance losses, reinsurance arrangements, underwriting performance and regulatory capital requirements on future margins and liquidity.
- Monitor NYSE listing compliance, trading liquidity, lockups and registration rights that may affect the future supply of common stock.
- Review the incorporated risk factors and related-party, compensation and indemnification arrangements.